Description
GHK-Cu is a synthetic tripeptide-copper complex demonstrating specific molecular interactions in experimental models. The compound consists of a glycyl-L-histidyl-L-lysine sequence chelated with copper, showing unique binding characteristics in laboratory studies. Research indicates selective interaction with cellular pathways under controlled experimental conditions, making it relevant for molecular and biochemical research applications.
Drago Pharma Properties
| Chemical Formula | C14H23CuN6O4+ |
| Synonyms | Prezatide copper; Copper peptide; BCP32687; SY253680; GHK copper; CG-copper peptide; [N2-(N-Glycyl-L-histidyl)-L-lysinato(2-)]copper |
| Molar Mass | 402.92 g/mol |
| CAS Number | 89030-95-5 |
| PubChem | 78122578 |
| Total Active Ingredient | 100mg total (10mg × 10 vials) or 50mg per vial |
| Shelf Life | 36 months |
Drago Pharma Important Notice
FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY. Products are not for human consumption.
Note: These peptides are freeze-dried, a process that extends shelf life and preserves purity and integrity during storage. No fillers are used in this process.
There are no reviews yet.